GlassScriptPhysician profile
Nancy Katherine Morris
NPI 1891778130
$5,590.75
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,898 · 2020: $1,212 · 2021: $2,482.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,206.00 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $828.55 | 2019-2021 | |
| Amgen INC. | $671.96 | 2019-2021 | |
| Pfizer INC. | $475.93 | 2019-2021 | |
| Horizon Therapeutics Plc | $393.49 | 2019-2021 | |
| Radius Health, INC. | $359.21 | 2019-2021 | |
| Glaxosmithkline, LLC. | $342.39 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $288.89 | 2020-2021 | |
| Janssen Biotech, INC. | $215.83 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $208.94 | 2019-2021 | |
| Lilly USA, LLC | $165.77 | 2019-2021 | |
| Ucb, INC. | $138.28 | 2019-2021 | |
| Aurinia Pharma U.S., INC. | $58.45 | 2021 | |
| Johnson & Johnson Health Care Systems INC. | $56.99 | 2019 | |
| Genzyme Corporation | $43.54 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $36.32 | 2019-2020 | |
| Sobi, INC | $28.35 | 2020 | |
| Sanofi-Aventis U.S. LLC | $24.38 | 2021 | |
| Genentech USA, INC. | $18.56 | 2021 | |
| Alexion Pharmaceuticals, INC. | $15.40 | 2019 | |
| Astellas Pharma US INC | $13.52 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.